Alexandria Real Estate Equities Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在住宅与商业类房地产信托基金(REIT)行业排名73/196位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价68.85。中期看,股价处于下降通道。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Alexandria Real Estate Equities Inc评分
相关信息
行业排名
73 / 196
全市场排名
151 / 4582
所属行业
住宅与商业类房地产信托基金(REIT)
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
15
位分析师
持有
评级
68.846
目标均价
+53.09%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Alexandria Real Estate Equities Inc亮点
亮点风险
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
公司代码ARE
公司Alexandria Real Estate Equities Inc
CEOMoglia (Peter M)
网址https://www.are.com/
常见问题
Alexandria Real Estate Equities Inc(ARE)的当前股价是多少?
Alexandria Real Estate Equities Inc(ARE)的当前股价是 47.960。
Alexandria Real Estate Equities Inc的股票代码是什么?
Alexandria Real Estate Equities Inc的股票代码是ARE。
Alexandria Real Estate Equities Inc股票的52周最高点是多少?
Alexandria Real Estate Equities Inc股票的52周最高点是105.140。
Alexandria Real Estate Equities Inc股票的52周最低点是多少?
Alexandria Real Estate Equities Inc股票的52周最低点是44.103。
Alexandria Real Estate Equities Inc的市值是多少?
Alexandria Real Estate Equities Inc的市值是8.17B。
Alexandria Real Estate Equities Inc的净利润是多少?
Alexandria Real Estate Equities Inc的净利润为309.56M。
现在Alexandria Real Estate Equities Inc(ARE)的股票是买入、持有还是卖出?
根据分析师评级,Alexandria Real Estate Equities Inc(ARE)的总体评级为持有,目标价格为68.846。
Alexandria Real Estate Equities Inc(ARE)股票的每股收益(EPS TTM)是多少
Alexandria Real Estate Equities Inc(ARE)股票的每股收益(EPS TTM)是-2.470。